BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blagov AV, Grechko AV, Nikiforov NG, Borisov EE, Sadykhov NK, Orekhov AN. Role of Impaired Mitochondrial Dynamics Processes in the Pathogenesis of Alzheimer’s Disease. IJMS 2022;23:6954. [DOI: 10.3390/ijms23136954] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Nejabati HR, Roshangar L. Kaempferol as a potential neuroprotector in Alzheimer's disease. J Food Biochem 2022;46:e14375. [PMID: 35929364 DOI: 10.1111/jfbc.14375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Khan T, Waseem R, Zehra Z, Aiman A, Bhardwaj P, Ansari J, Hassan MI, Islam A. Mitochondrial Dysfunction: Pathophysiology and Mitochondria-Targeted Drug Delivery Approaches. Pharmaceutics 2022;14. [PMID: 36559149 DOI: 10.3390/pharmaceutics14122657] [Reference Citation Analysis]
3 Arnst N, Redolfi N, Lia A, Bedetta M, Greotti E, Pizzo P. Mitochondrial Ca(2+) Signaling and Bioenergetics in Alzheimer's Disease. Biomedicines 2022;10. [PMID: 36551781 DOI: 10.3390/biomedicines10123025] [Reference Citation Analysis]
4 C Silva T, Zhang W, Young JI, Gomez L, Schmidt MA, Varma A, Chen XS, Martin ER, Wang L. Distinct sex-specific DNA methylation differences in Alzheimer's disease. Alzheimers Res Ther 2022;14:133. [PMID: 36109771 DOI: 10.1186/s13195-022-01070-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]